Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 3 to 7, 2022. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Jan. 3 to 7, 2022. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
White House Finalizes Plan to Send Americans Free COVID-19 Rapid Tests
FRIDAY, Jan. 7, 2022 (HealthDay News) — The final touches are being put on the White House’s plan to deliver 500 million free COVID-19 rapid at-home test kits to households across America.
FDA Shortens Time to Booster After Moderna Vaccine to Five Months
FRIDAY, Jan. 7, 2022 (HealthDay News) — Citing the rapid spread of the omicron variant and the need for protection against it, U.S. federal health officials are shortening the recommended time between the second dose of the Moderna vaccine and a booster shot from six months down to five.
Moderna CEO Says Fourth COVID-19 Dose May Be Needed Next Fall
FRIDAY, Jan. 7, 2022 (HealthDay News) — A fourth COVID-19 vaccine may be needed for most people by next fall because of what will likely be waning immunity, Moderna CEO Stephane Bancel said Thursday.
Supreme Court Hears Arguments on Biden’s Vaccine Mandate for Big Business
FRIDAY, Jan. 7, 2022 (HealthDay News) — The Supreme Court began to hear oral arguments on Friday as it weighs whether the Biden administration can enforce vaccine mandates for large companies. The justices are also hearing arguments on a separate vaccine mandate for most health care workers.
Hospitals Are Rationing COVID-19 Pills, Infusions as Cases Rise
FRIDAY, Jan. 7, 2022 (HealthDay News) — It is the ultimate irony: More COVID-19 treatments exist now than at any other time during the pandemic, but the skyrocketing number of cases from the surging omicron variant might mean they cannot be accessed when needed most.
Effect of Types of Screen Use on Child Mental Health Examined
FRIDAY, Jan. 7, 2022 (HealthDay News) — Higher levels of screen use are associated with poor mental health for children and youth during the COVID-19 pandemic, according to a study published online Dec. 28 in JAMA Network Open.
Vaccination Seems Less Protective Against Transmission of Delta Variant
FRIDAY, Jan. 7, 2022 (HealthDay News) — COVID-19 vaccination is associated with a smaller reduction in transmission of the delta variant compared with the alpha variant of severe acute respiratory syndrome coronavirus 2, according to a study published online Jan. 5 in the New England Journal of Medicine.
COVID-19 Vaccines Significantly Cut MIS-C Risk in Teens
FRIDAY, Jan. 7, 2022 (HealthDay News) — COVID-19 mRNA vaccination is associated with a lower incidence of multisystem inflammatory syndrome in children in adolescents, according to a research letter published online Dec. 20 in the Journal of the American Medical Association.
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia 
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease 
Trends Reported in Vaccination Coverage for Adolescents for 2025 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
Adverse Event Risk Not Up With Same Day COVID-19, Flu Vaccination 
.jpeg)
